Your browser doesn't support javascript.
loading
Anti-TL1A Antibody PF-06480605 Safety and Efficacy for Ulcerative Colitis: A Phase 2a Single-Arm Study.
Danese, Silvio; Klopocka, Maria; Scherl, Ellen J; Romatowski, Jacek; Allegretti, Jessica R; Peeva, Elena; Vincent, Michael S; Schoenbeck, Uwe; Ye, Zhan; Hassan-Zahraee, Mina; Rath, Natalie; Li, Gang; Neelakantan, Srividya; Banfield, Christopher; Lepsy, Christopher; Chandra, Deepa E; Hung, Kenneth E.
Afiliação
  • Danese S; IBD Center, Humanitas Clinical and Research Center-IRCCS, Milan, Italy; Humanitas Research Hospital, Department of Biomedical Sciences, Milan Italy; University Vita-Salute San Raffaele, Milan, Italy. Electronic address: sdanese@hotmail.com.
  • Klopocka M; Nicolaus Copernicus University in Torun, Collegium Medicum, Department of Gastroenterology and Nutrition, Bydgoszcz, Poland.
  • Scherl EJ; Jill Roberts Center for IBD, Weill Cornell Medicine, Division of Gastroenterology and Hepatology, New York, New York.
  • Romatowski J; J. Sniadecki's Regional Hospital, Internal Medicine and Gastroenterology Department, Bialystok, Poland.
  • Allegretti JR; Brigham and Women's Hospital, Harvard Medical School, Division of Gastroenterology, Boston, Massachusetts.
  • Peeva E; Pfizer Inc, Cambridge, Massachusetts.
  • Vincent MS; Pfizer Inc, Cambridge, Massachusetts.
  • Schoenbeck U; Pfizer Inc, New York, New York.
  • Ye Z; Pfizer Inc, Cambridge, Massachusetts.
  • Hassan-Zahraee M; Pfizer Inc, Cambridge, Massachusetts.
  • Rath N; Pfizer Inc, Collegeville, Pennsylvania.
  • Li G; Pfizer Inc, Collegeville, Pennsylvania.
  • Neelakantan S; Pfizer Inc, Cambridge, Massachusetts.
  • Banfield C; Pfizer Inc, Cambridge, Massachusetts.
  • Lepsy C; Pfizer Inc, Andover, Massachusetts.
  • Chandra DE; Pfizer Inc, Cambridge, Massachusetts.
  • Hung KE; Pfizer Inc, Cambridge, Massachusetts.
Clin Gastroenterol Hepatol ; 19(11): 2324-2332.e6, 2021 11.
Article em En | MEDLINE | ID: mdl-34126262

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Colite Ulcerativa / Antineoplásicos Imunológicos Tipo de estudo: Clinical_trials / Guideline Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Colite Ulcerativa / Antineoplásicos Imunológicos Tipo de estudo: Clinical_trials / Guideline Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article